Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The silent dragon--hepatitis C.

Beverly Walker1, Linda Howard

  • 1Franciscan Health System, Tacoma, Wash, USA.

AORN Journal
|June 24, 2003
PubMed
Summary

Hepatitis C virus (HCV) is a leading global bloodborne pathogen causing significant mortality. While treatments like interferon and ribavirin exist, research into evolving therapies and transplantation offers hope for millions infected worldwide.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis.

Journal for immunotherapy of cancer·2025
Same author

Optimization of 3D Extrusion-Printed Particle-Containing Hydrogels for Osteogenic Differentiation.

ACS omega·2025
Same author

Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson's and Alzheimer's Disease.

Biomedicines·2023
Same author

Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with "no-option" critical limb ischemia; observations on feasibility of the autologous approach from a clinical trial.

Cytotherapy·2022
Same author

Corrigendum to "Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)" [Stem Cell Res. (43) 2020 101665].

Stem cell research·2022
Same author

Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury.

Cells·2021

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) is the most prevalent bloodborne pathogen globally.
  • HCV infection results in substantial annual mortality in the United States.
  • Understanding HCV's progression and differentiation from other hepatitis viruses is a recent scientific focus.

Observation:

  • HCV transmission primarily occurs through direct percutaneous exposure.
  • The disease disproportionately affects minority populations.
  • Current first-line treatments include alpha interferon and ribavirin.

Findings:

  • HCV remains a significant global health challenge with no current cure or vaccine.
  • Annual mortality rates from HCV in the US range from 8,000 to 10,000.
  • Recent advancements are improving the understanding of HCV's natural history.

Implications:

  • Evolving medication therapies show promise for managing HCV infection.
  • Liver transplantation, including deceased and living donor options, offers a potential solution for severe cases.
  • An estimated 170 million people worldwide are infected with the hepatitis C virus, highlighting the need for effective interventions.

Related Experiment Videos